Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc.

PBHยทNYSE

$45.44

-1.1%
HealthcareMedical - Distribution

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

At a Glance

Live Snapshot
Market Cap$2.15B
EPS3.9300
P/E Ratio11.56
Earnings Date08/06/2026
Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. Fair Value Envelope

PBH ยท NYSE

Our analysis suggests that PBH has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $45.44, this represents a potential HIDDEN relative to our calculated worth for Prestige Consumer Healthcare Inc..

Intrinsic Value
Current Price: $45.44

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$4.1B
+ Cash & Equivalents$63.9M
Firm Value$4.2B
- Debt$48.5M
Equity Value$4.1B
/ Shares Outstanding49,438,116B
DCF Value$84
UNDERVALUED BY 84%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$261.0M
$264.4M
$267.8M
$271.3M
$274.8M
$278.4M
$282.0M
$285.6M
$289.3M
$293.1M
Maintenance CapEx
-$2.3M
-$2.3M
-$2.3M
-$2.4M
-$2.4M
-$2.4M
-$2.4M
-$2.5M
-$2.5M
-$2.5M
Owner Earnings
$258.7M
$262.1M
$265.5M
$268.9M
$272.4M
$275.9M
$279.5M
$283.1M
$286.8M
$290.5M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$239.5M
$224.7M
$210.7M
$197.7M
$185.4M
$173.9M
$163.1M
$153.0M
$143.5M
$134.6M
Terminal Value represents 55.6% of Enterprise Value